✦ LIBER ✦

1165 CLINICAL UTILITY OF THE ARCHITECT HCV AG ASSAY FOR EARLY TREATMENT RESPONSE MONITORING IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION

✍ Scribed by Vermehren, J.; Süsser, S.; Berger, A.; Perner, D.; Peiffer, K.H.; Zeuzem, S.; Sarrazin, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical utility of the ARCHITECT HCV Ag

✍ Johannes Vermehren; Simone Susser; Annemarie Berger; Dany Perner; Kai-Henrik Pei 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Treatment of Chronic Hepatitis C Genotyp

✍ Sood, Ajit; Midha, Vandana; Goyal, Omesh; Sood, Neena; Sharma, Suresh 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 63 KB

1166 CLINICAL RELEVANCE OF MINIMAL RESID

✍ Vermehren, J.; Süsser, S.; Perner, D.; Füller, C.; Zeuzem, S.; Sarrazin, C. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Factors associated with rapid and early

✍ M. Rodriguez-Torres; M. S. Sulkowski; R. T. Chung; F. M. Hamzeh; D. M. Jensen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

PIN32 Economic Evaluation of Boceprevir

✍ R. Odhiambo; J. Chhatwal; S.A. Ferrante; A. El Khoury; E. Elbasha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Early anemia and rapid virological respo

✍ Ahmad Amanzada; Simon Schneider; Federico Moriconi; Alexander Lindhorst; Thomas 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB